All posts tagged "Todos Medical"
-
232BiotechThe Next Axcella (AXLA) Squeeze –> Bioxytran (BIXT)
Axcella Therapeutics (NASDAQ: AXLA) mesmerized investors yesterday with news of a patent to treat fatigue in Long COVID. The short squeeze setup...
-
804BiotechTodos Medical (TOMDF) Inks Transformative CBD Supply Deal After Hours
Todos Medical Inc. (OTCMKTS: TOMDF) announced yesterday a $50 million supply contract of Tollovid and CBD products to Nerd Hemp an AI...
-
895BiotechTodos Medical (TOMDF) The Ultimate Pandemic Stock
Monkeypox Following in COVID’s Footsteps: Possible Back-to-Back Pandemics Todos Medical (OTCMKTS: TOMDF) is the ultimate pandemic stock because they win no matter...
-
865BiotechTodos (TOMDF) Leapfrogs Applied DNA (APDN) and Leads in the MonkeyPox Testing Race
Doubles National MonkeyPox testing capacity Todos Medical Inc. (OTMKTS: TOMDF) announced the validation of its MonkeyPox lesion and saliva-based test. Other than...
-
7031BiotechMonkeypox Stocks Heating Up the Charts: TOMDF APDN CODX
Investors are facing the sober reality of a twin pandemic, COVID-19, and monkeypox. It’s now clear that the government missed the opportunity...
-
1.0K1BiotechVeru’s (NASDAQ: VERU) Repurposed COVID-19 Drug Facing Uphill Battle for EUA
At first glance Veru, Inc.’s (NASDAQ: VERU) COVID-19 therapy phase 3 top line results were notable but their battle for an emergency...
-
1.9KBiotechTodos (OTCMKTS: TOMDF) CEO Nails NewsMax Interview With Critical Messages About the Pandemic
This Saturday Todos Medical’s (OTCMKTS: TOMDF) CEO set the stage for future international media exposure. This interview was powerful, gripping, and informative...
-
1.0KBiotechWhy Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack
Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...
-
894BiotechThe 3CL Secret to Pfizer’s and Todos Medical’s Success
Pfizer’s (NYSE: PFE) PAXLOVID has risen to prominence as the top COVID-19 antiviral in the world. The speed at which they rose...
-
3.1KBiotechAtea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...